FTC official: Illumina/PacBio was a “future innovation story”
Credit: CI Photos/Shutterstock
The US Federal Trade Commission’s deputy director of competition has shed light on her agency’s challenge to the now-abandoned Illumina/Pacific Biosciences deal.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now